Schoeneck James A

Average Profitability
<0.0001%
Insider Buys Quantity
2
Insider Buys Sum
$105,040.00
Insider Sells Quantity
8
Insider Sells Sum
$1.42M

Insider Activity of Schoeneck James A

According to the SEC Form 4 filings, Schoeneck James A, being in a position of

  1. director at FibroGen, Inc.,
    оver the last 12 months, has bought 300000 shares for $105,040, and sold 0 shares,
    over all time since 2018-06-22, has bought 300000 shares for $105,040, and sold 29100 shares for $1.42M.

The largest purchase of all time was on 2025-03-20 and amounted to 250000 shares of FibroGen, Inc. for $88,000.

The largest sale of all time was on 2018-07-03 and amounted to 7639 shares of FibroGen, Inc. for $496,535.

Biography of Schoeneck James A

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $105,0402100
Sells
 $000

Comparison of Insiders on Amount of Buys and Sells

2025-03-21PurchaseFibroGen, Inc.
FGEN
director
50,000
0.0536%
$0.34$17,040+8.6%
2025-03-20PurchaseFibroGen, Inc.
FGEN
director
250,000
0.2595%
$0.35$88,000-0.01%
2023-06-07SaleFibroGen, Inc.
FGEN
director
7,100
0.0079%
$18.03$127,987-93.02%
2019-05-07SaleFibroGen, Inc.
FGEN
director
2,000
0.0024%
$47.02$94,045-9.65%
2019-04-08SaleFibroGen, Inc.
FGEN
director
2,000
0.0023%
$52.90$105,800-19.88%
2019-03-07SaleFibroGen, Inc.
FGEN
director
2,000
0.0023%
$54.74$109,472-20.87%
2019-02-07SaleFibroGen, Inc.
FGEN
director
2,000
0.0024%
$57.17$114,340-20.68%
2019-01-07SaleFibroGen, Inc.
FGEN
director
2,000
0.0023%
$45.90$91,800-3.38%
2018-07-03SaleFibroGen, Inc.
FGEN
director
7,639
0.009%
$65.00$496,535-18.83%
2018-06-22SaleFibroGen, Inc.
FGEN
director
4,361
0.0052%
$65.00$283,465-18.01%
Total: 10
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.